Biolife Solutions (BLFS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 48,087 | 27,371 | 19,742 | 11,022 | 8,227 |
| Cost of Goods | 20,646 | 8,760 | 6,217 | 4,276 | 3,448 |
| Gross Profit | 27,441 | 18,611 | 13,525 | 6,746 | 4,779 |
| Operating Expenses | 34,328 | 19,591 | 10,080 | 8,078 | 10,079 |
| Operating Income | -6,241 | -220 | 3,662 | -1,056 | -4,852 |
| Interest Expense | 0 | 0 | 5 | 190 | 100 |
| Other Income | 4,960 | -2,978 | -28,662 | -1,269 | -3,090 |
| Pre-tax Income | -1,281 | -3,198 | -25,005 | -2,515 | -8,041 |
| Income Tax | -3,264 | -1,541 | N/A | N/A | N/A |
| Net Income Continuous | 1,983 | -1,657 | -25,005 | -2,515 | -8,041 |
| Minority Interests | N/A | N/A | N/A | N/A | -1,166 |
| Net Income | $1,983 | $-1,657 | $-25,005 | $-2,515 | $-6,875 |
| EPS Basic Total Ops | 0.07 | -0.09 | -1.56 | -0.21 | -0.54 |
| EPS Basic Continuous Ops | 0.07 | -0.09 | -1.54 | -0.19 | -0.64 |
| EPS Diluted Total Ops | -0.06 | -0.09 | -1.56 | -0.21 | -0.54 |
| EPS Diluted Continuous Ops | 0.07 | -0.09 | -1.54 | -0.19 | -0.64 |
| EPS Diluted Before Non-Recurring Items | 0.01 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-1,173 | $1,577 | $4,000 | $-620 | $-4,305 |